Switch to the original Schedule Online view

Community Schedule

Enter at least 4 characters

0 matches for: 'meningococcal c conjugate vaccine' in the Therapeutic Groups

1 results showing for: 'meningococcal c conjugate vaccine'

Meningococcal C conjugate vaccine

[Xpharm]
  • Inj 10 mcg in 0.5 ml syringe
    • Brand Fully subsidised brand. Neisvac-C
    • Pharmacode2461919
    • Subsidy $0.00
    • Measure / Qty per 1

Both:

  1. The child is under 9 months of age; and

  2. Any of the following:

    1. Up to three doses for patients pre- and post splenectomy and for patients with functional or anatomic asplenia, HIV, complement deficiency (acquired or inherited), or pre or post solid organ transplant; or

    2. Two doses for close contacts of meningococcal cases of any group; or

    3. Two doses for child who has previously had meningococcal disease of any group; or

    4. A maximum of two doses for bone marrow transplant patients; or

    5. A maximum of two doses for child pre- and post-immunosuppression*.

    Note: children under nine months of age require two doses 8 weeks apart. Refer to the Immunisation Handbook for booster schedules with meningococcal ACWY vaccine.

    *Immunosuppression due to steroid or other immunosuppressive therapy must be for a period of greater than 28 days.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • B Bolded Pharmacode means that the product is to be delisted soon
  • Sole Subsidised Supply